Spain News
IMS Launch New Spanish Mortgage Service
International Mortgage Solutions, Spain’s premier independent mortgage broker for Spanish mortgages has announced the launch of their new process and packaging service. - August 16, 2006 - IMS Ltd
A Full Pipeline of Follow-on TNF-Antagonists
The US$ 7.6 bln market of TNF-antagonists attracts numerous follow-on compounds including improved TNF-antagonists and molecules originating from new technologies. - August 02, 2006 - La Merie Business Intelligence
Youngest Costa is Coming of Age
The Costa de la Luz, stretching for 417km from Tarifa to the Portuguese border, has been and still is often described as ‘the hidden Costa’ or the ‘undiscovered Costa’, although those on the ground would argue that neither of these descriptions are particularly accurate anymore. In fact the Costa de la Luz has been growing steadily and tastefully into what is now a well-rounded second home and tourist hotspot. - July 25, 2006 - Titan Properties
Biogenerics and New Technologies Compete with 1st Generation Major Products
The US$ 32 bln market of six major protein products is enfacing competition by less costly biogenerics and by improved products via drug delivery or protein engineering technologies and even oral, small molecule solutions. - June 20, 2006 - La Merie Business Intelligence
Imminent Launches of New EPO Products and Consolidation of the Biogenerics Field
The Business Intelligence firm La Merie S.L. reported today changes in the field of erythropoiesis stimulating agents (ESA) observed in a follow-up analysis. The first launch of a new ESA in Europe is expected to be Shire’s epoetin omega in the first half of 2007 to be followed by... - June 03, 2006 - La Merie Business Intelligence
Localized Delivery of PDE-4 Inhibitors to Open the Therapeutic Window
The Localized delivery of phosphodiesterase-4 (PDE-4) inhibitors appears to be short term solution to overcome the dose-limiting side effects of severe nausea and emesis occurring after oral administration. In the long-term, subtype-selective PDE-4 inhibitors and combination regimens may help to improve the therapeutic index. - May 31, 2006 - La Merie Business Intelligence
The Next Generation of Interferons Needs Improvement in Efficacy and Safety
The interferon alpha market is smaller than the interferon beta market, but is characterized by far more products and R&D projects. Conversion of the interferon alpha market to pegylated products explains why new R&D is focused on interferon alpha variants or other subtypes with improved pharmacodynamic and safety properties. - May 19, 2006 - La Merie Business Intelligence
Gextech to Demonstrate Smart-Stitch Powerhouse Technology at GIGSE ‘06
Interactive gaming content provider, Gextech has unveiled details of Smart-Stitch, the driving force behind Fantastic League – its new virtual fixed odds football betting game for multiple platforms including interactive TV, internet, mobile and terminal delivery. - May 18, 2006 - Gex Technologies
RNA Interference (RNAi) is Coming of Age as a Therapeutic Modality
The Business Intelligence firm La Merie S.L. reported today that the RNAi therapeutic pipeline is rapidly filling and advancing towards clinical development. Four RNAi therapeutic projects are in early clinical development. At least 32 RNAi projects are in preclinical development in a variety of... - May 10, 2006 - La Merie Business Intelligence
Spanishpromotions: Spain in a Click
The digital platform spanishpromotions.com, managed by the company Briggs International Consulting achieved its best results as regards its number of visitors during last December, confirming the rising trend it experienced during the second half of the year - March 21, 2006 - Briggs International Consulting
Spanish Language: World´s 2nd Fastest Growing Language. Are you Studyng it?
How to improve your Spanish? As most language teachers recommend once the basics are familiar, nothing beats immersion in order to gain command and fluency in the language. And if possible, doing something of your interest. - March 14, 2006 - Fun Time in Spain
Antibodies are the First Wave of IGF-1R Antagonists for Cancer Therapy
At least six fully human or humanized antibodies against insulin-like growth factor-1 receptor (IGF-1R) are in early clinical development or close to phase I. - March 07, 2006 - La Merie Business Intelligence
Binary Worlds Launches Big Kakuro Puzzles Syndication Service
Binary Worlds, challenging puzzles provider, today announced its big Kakuro puzzles syndication service. The Kakuros come in different sizes, from 4x4 to 14x14 puzzles. - March 02, 2006 - Binary Worlds SL
Dawn has Broken for Obesity Treatment with Cannabinoid Receptor (CB1) Antagonists
Tremendous impetus to discovery of novel CB1 antagonists by first-in-class CB1 receptor antagonist rimonabant under review by FDA and EMEA - February 22, 2006 - La Merie Business Intelligence
Top 20 Biologics Now with Sales of US$ 37.7 Bln in 2005
The Top 20 blockbuster recombinant proteins and antibodies achieved record sales of US$ 37.7 bln in the year 2005 while combined sales of the 12 Top selling classes of recombinant proteins and antibodies reached the US$ 50 bln threshold. - February 15, 2006 - La Merie Business Intelligence
Dosing Convenience Mandates the Pipeline of Glucagon-like Peptide-1 (GLP-1) Analogs for Type 2 Diabetes
Twice-daily injection is the benchmark set by exenatide, the first GLP-1 analog launched in the US by Lilly in June 2005 and half-year sales of US$ 74.6 mln, which now faces competition by GLP-1 analog treatment modalities with less frequent dosing. - February 07, 2006 - La Merie Business Intelligence
Emerging Diabetes Drugs in Early Development
The complexity of glucose metabolism and the number of cellular processes affected by diabetes provides ample space for new drug targets and for first-in-class molecules. Some of them have reached or are close to early clinical development in type 2 diabetes. - January 31, 2006 - La Merie Business Intelligence
Private Investor Achieves 38% Return Since 1985
Leonard Berney proves that his trading system can be very profitable and gives away his 'secret' free of charge. - January 24, 2006 - Leonard Berney
High Interest in Inhibitors of the Novel Target Sodium-dependent Glucose (co-) Transporter (SGLT) for Therapy of Type 2 Diabetes
A plethora of SGLT inhibitors in the patent literature and seven compounds in early clinical development indicate an abundance of interest in the therapeutic use of SGLT inhibitors for the treatment of type 2 diabetes. SGLT inhibitors do not intervene with glucose metabolism, thus being complementary to mainstream approaches to glucose regulation, i.e. PPAR agonists, DPP-IV antagonists and GLP-1 analogues. - January 24, 2006 - La Merie Business Intelligence
Cardiovascular safety determines the direction of PPAR agonist R&D
The two peroxisome proliferator-activated receptor (PPAR) gamma agonists pioglitazone and rosiglitazone approved for treatment of type 2 diabetes achieved combined 2004 global sales of US$ 3.96 bln shared between Takeda & Eli Lilly (52 %) and GlaxoSmithKline (48 %). - November 28, 2005 - La Merie Business Intelligence
Competition is Needed in the Follicle Stimulating Hormone (FSH) Market
Ten years after the first approval of a recombinant human FSH for treatment of infertility the US$ 0.9 bln global market of recombinant human FSH (rhFSH) in 2004 was shared between Serono (63 % for follitropin alfa) and Organon (37 % for follitropin beta). - November 14, 2005 - La Merie Business Intelligence
Solo Para Niños - Making Life Easier
Internet users in Barcelona, Spain, woke up this morning to discover a new and exciting specialised search engine and directory available for them to use, called SPN Solo para niños. Without the full financial resources available to the "big boys" in the market, this growing... - July 26, 2005 - Solo Para Niños SL
CAN World Trade Directory announces the introduction of one of the Internets most advanced and innovative Restaurant Guides
Incorporated as a special category within the CAN World Trade Directory, the Restaurant Guide has many management resources not found in other directories. - June 02, 2005 - Community Action Network S.L.